Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10928480rdf:typepubmed:Citationlld:pubmed
pubmed-article:10928480lifeskim:mentionsumls-concept:C0019904lld:lifeskim
pubmed-article:10928480lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:10928480lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:10928480lifeskim:mentionsumls-concept:C0003765lld:lifeskim
pubmed-article:10928480lifeskim:mentionsumls-concept:C0005129lld:lifeskim
pubmed-article:10928480lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:10928480lifeskim:mentionsumls-concept:C0086816lld:lifeskim
pubmed-article:10928480pubmed:issue1lld:pubmed
pubmed-article:10928480pubmed:dateCreated2001-2-2lld:pubmed
pubmed-article:10928480pubmed:abstractTextBernard-Soulier syndrome (BSS) is an autosomal recessive bleeding disorder due to quantitative or qualitative abnormalities in the glycoprotein (GP) Ib/IX/V complex, the platelet receptor for von Willebrand factor. This complex is composed of four subunits, GPIbalpha, GPIbbeta, GPIX and GPV. We describe here the genetic basis of the disorder in a patient with BSS. Flow cytometric analysis of the patient's platelets showed greatly reduced GPIbalpha and GPIX surface expression. Immunoblot analysis disclosed absence of GPIbalpha, GPIbbeta and GPIX in the platelets. DNA sequencing analysis revealed a novel missense mutation in the GPIbbeta gene that converts Pro (CCG) to Arg (CGG) at residue 74. Homozygosity of the mutation was confirmed by allele-specific restriction analysis, chromosome 22 microsatellite analysis and quantitative Southern blotting. The mutant GPIbbeta was normally transcribed. Transient transfection studies confirmed that mutant GPIbbeta impairs surface expression of GPIb/IX, showing that the mutation is responsible for a BSS phenotype observed in the patient.lld:pubmed
pubmed-article:10928480pubmed:languageenglld:pubmed
pubmed-article:10928480pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10928480pubmed:citationSubsetIMlld:pubmed
pubmed-article:10928480pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10928480pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10928480pubmed:statusMEDLINElld:pubmed
pubmed-article:10928480pubmed:monthJullld:pubmed
pubmed-article:10928480pubmed:issn0340-6245lld:pubmed
pubmed-article:10928480pubmed:authorpubmed-author:KamiyaTTlld:pubmed
pubmed-article:10928480pubmed:authorpubmed-author:SaitoHHlld:pubmed
pubmed-article:10928480pubmed:authorpubmed-author:HaraJJlld:pubmed
pubmed-article:10928480pubmed:authorpubmed-author:HondaSSlld:pubmed
pubmed-article:10928480pubmed:authorpubmed-author:InoueCClld:pubmed
pubmed-article:10928480pubmed:authorpubmed-author:TomiyamaYYlld:pubmed
pubmed-article:10928480pubmed:authorpubmed-author:KunishimaSSlld:pubmed
pubmed-article:10928480pubmed:authorpubmed-author:FukunishiMMlld:pubmed
pubmed-article:10928480pubmed:issnTypePrintlld:pubmed
pubmed-article:10928480pubmed:volume84lld:pubmed
pubmed-article:10928480pubmed:ownerNLMlld:pubmed
pubmed-article:10928480pubmed:authorsCompleteYlld:pubmed
pubmed-article:10928480pubmed:pagination112-7lld:pubmed
pubmed-article:10928480pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10928480pubmed:meshHeadingpubmed-meshheading:10928480...lld:pubmed
pubmed-article:10928480pubmed:meshHeadingpubmed-meshheading:10928480...lld:pubmed
pubmed-article:10928480pubmed:meshHeadingpubmed-meshheading:10928480...lld:pubmed
pubmed-article:10928480pubmed:meshHeadingpubmed-meshheading:10928480...lld:pubmed
pubmed-article:10928480pubmed:meshHeadingpubmed-meshheading:10928480...lld:pubmed
pubmed-article:10928480pubmed:meshHeadingpubmed-meshheading:10928480...lld:pubmed
pubmed-article:10928480pubmed:meshHeadingpubmed-meshheading:10928480...lld:pubmed
pubmed-article:10928480pubmed:meshHeadingpubmed-meshheading:10928480...lld:pubmed
pubmed-article:10928480pubmed:meshHeadingpubmed-meshheading:10928480...lld:pubmed
pubmed-article:10928480pubmed:meshHeadingpubmed-meshheading:10928480...lld:pubmed
pubmed-article:10928480pubmed:meshHeadingpubmed-meshheading:10928480...lld:pubmed
pubmed-article:10928480pubmed:meshHeadingpubmed-meshheading:10928480...lld:pubmed
pubmed-article:10928480pubmed:meshHeadingpubmed-meshheading:10928480...lld:pubmed
pubmed-article:10928480pubmed:meshHeadingpubmed-meshheading:10928480...lld:pubmed
pubmed-article:10928480pubmed:meshHeadingpubmed-meshheading:10928480...lld:pubmed
pubmed-article:10928480pubmed:year2000lld:pubmed
pubmed-article:10928480pubmed:articleTitleHomozygous Pro74-->Arg mutation in the platelet glycoprotein Ibbeta gene associated with Bernard-Soulier syndrome.lld:pubmed
pubmed-article:10928480pubmed:affiliationJapanese Red Cross Aichi Blood Center, Seto, Japan. kunisima@fujita-hu.ac.jplld:pubmed
pubmed-article:10928480pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10928480pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:10928480pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10928480lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10928480lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10928480lld:pubmed